BASF has announced plans to build a world-scale ibuprofen production plant in Ludwigshafen, Germany, which is scheduled to be completed in 2021. Additionally, it will expand its facilities in Bishop, Texas, to be completed in early 2018.
Ibuprofen
The overall investment for both projects will be around €200 million and the company reports this investment will assist in filling current market gaps and meeting the growth in demand for ibuprofen globally.
“It will be the first world-scale ibuprofen plant in Europe,” stated Dr Markus Kamieth, member of the board of executive directors, BASF SE. “BASF will be the only supplier with two ibuprofen assets worldwide. This makes us a highly reliable partner for our customers.”
“Both investments show our strong commitment to the pharmaceutical industry and our pharma solutions business,” added Dr Melanie Maas-Brunner, president of BASF’s Nutrition & Health business. “They enable us to close supply gaps and efficiently support our customers’ growth plans.”